Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Morningside Healthcare Ltd, Unit C, Harcourt Way, Leicester, LE19 1WP, UK
Vensir XL 75mg prolonged release hard capsules.
Venlafaxine Morningside 75mg prolonged release hard capsules.
| Pharmaceutical Form |
|---|
|
Prolonged release capsules, hard. The capsules are peach opaque/peach opaque size ‘1’ hard gelatin capsules having thick and thin radial circular band on the body in red ink and thick and thin radial circular band on the cap in red ink. The capsule is filled with 6 white to off-white round biconvex film coated mini tablets of 12.5mg. |
Each capsule contains venlafaxine hydrochloride equivalent to 75mg of venlafaxine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Venlafaxine |
Venlafaxine has an antidepressant effect. The mechanism of its action in humans is believed to be associated with its potentiation of neurotransmitter activity in the central nervous system. |
| List of Excipients |
|---|
|
Microcrystalline cellulose Capsule shell components: Gelatin Printing ink: Shellac |
PVC/ACLAR* film and Aluminium lidding foil.
PVC/PVdC film and Aluminium foil.
Blister packs of 10, 14, 15 20, 28, 30, 56, 60 and 100 capsules.
Not all pack sizes may be marketed.
Morningside Healthcare Ltd, Unit C, Harcourt Way, Leicester, LE19 1WP, UK
PL 20117/0067
01/02/2012
| Drug | Countries | |
|---|---|---|
| VENSIR | Ireland, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
